
Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology… Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIR...
Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology… Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIR...